Fabry disease: The need to stratify patient populations to better understand the outcome of enzyme replacement therapy

被引：16

作者：

Germain, Dominique P. ^{[1
]}

机构：

[1] Assistance Publ Hop Paris, Ctr Reference Malad Fabry & Malad Hereditaires Ti, Paris, France

来源：

CLINICAL THERAPEUTICS | 2007年 / 29卷

关键词：

D O I：

10.1016/S0149-2918(07)80122-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：S17 / S18

页数：2

共 10 条

[1] Agalsidase-beta therapy for advanced Fabry disease - A randomized trial [J].

Banikazemi, Maryam ;

Bultas, Jan ;

Waldek, Stephen ;

Wilcox, William R. ;

Whitley, Chester B. ;

McDonald, Marie ;

Finkel, Richard ;

Packman, Seymour ;

Bichet, Daniel G. ;

Warnock, David G. ;

Desnick, Robert J. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (02) :77-86

[2] Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy [J].

Beer, Meinrad ;

Weidemann, Frank ;

Breunig, Frank ;

Knoll, Anita ;

Koeppe, Sabrina ;

Machann, Wolfram ;

Hahn, Dietbert ;

Wanner, Christoph ;

Strotmann, Jorg ;

Sandstede, Jorn .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10) :1515-1518

[3] Enzyme-replacement therapy for metabolic storage disorders [J].

Brady, RO ;

Schiffmann, R .

LANCET NEUROLOGY, 2004, 3 (12) :752-756

[4] Clinical benefit of enzyme replacement therapy in Fabry disease [J].

Breunig, F ;

Weidemann, F ;

Strotmann, J ;

Knoll, A ;

Wanner, C .

KIDNEY INTERNATIONAL, 2006, 69 (07) :1216-1221

[5] Enzyme replacement therapy for Fabry disease:: lessons from two α-galactosidase A orphan products and one FDA approval [J].

Desnick, RJ .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (07) :1167-1176

[6] Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].

Eng, CM ;

Guffon, N ;

Wilcox, WR ;

Germain, DP ;

Lee, P ;

Waldek, S ;

Caplan, L ;

Linthorst, GE ;

Desnick, RJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16

[7] Fabry disease: from the discovery of lysosomes to enzyme replacement therapy [J].

Germain, DP .

M S-MEDECINE SCIENCES, 2005, 21 :5-7

[8]

GERMAIN DP, IN PRESS J AM SOC NE

[9] Enzyme replacement therapy in Fabry disease - A randomized controlled trial [J].

Schiffmann, R ;

Kopp, JB ;

Austin, HA ;

Sabnis, S ;

Moore, DF ;

Weibel, T ;

Balow, JE ;

Brady, RO .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2743-2749

[10] Long-term safety and efficacy of enzyme replacement therapy for Fabry disease [J].

Wilcox, WR ;

Banikazemi, M ;

Guffon, N ;

Waldek, S ;

Lee, P ;

Linthorst, GE ;

Desnick, RJ ;

Germain, DP .

AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (01) :65-74

← 1 →